Peter L Barker

Title: Innovations by Peter L. Barker: Advancements in Pharmaceutical Compounds

Introduction

Peter L. Barker, a distinguished inventor based in Pleasanton, CA, has made significant contributions to the field of pharmaceuticals through his innovative work. With a portfolio comprising two patents, Barker has successfully devised compounds aimed at enhancing the bioavailability of therapeutic agents, showcasing his commitment to improving healthcare outcomes.

Latest Patents

Barker’s latest inventions include two noteworthy patents. The first, titled "Phosphocholine Linked Prodrug Derivatives," focuses on compounds designed to function as prodrugs. These compounds, characterized by their innovative linkers, enhance the bioavailability of linked therapeutic agents, particularly in the context of alcohol-containing, water-insoluble steroids. The meticulous design of the linkers, which can be variously substituted or unsubstituted, is pivotal to their effectiveness. This patent highlights not only the complexity of the compounds but also their potential applications in pharmaceuticals.

The second patent, "Phosphocholine Surfactants and Their Use," describes a pharmaceutical formulation that incorporates a sterol phosphocholine surfactant along with a pharmaceutically active agent that is either insoluble or sparingly soluble in water. This exploration into surfactants opens new avenues for drug formulation, particularly for challenging compounds, and underscores Barker’s innovative approach to pharmaceutical challenges.

Career Highlights

Throughout his career at Supergen, Inc., Barker has played an instrumental role in research and development, contributing to breakthroughs that hold the promise of enhancing drug efficacy. His extensive knowledge in chemistry and pharmaceutical sciences has positioned him as a significant figure within his organization and the broader scientific community.

Collaborations

Barker collaborates with fellow experts in the field, including Bruce H. Morimoto and Vincent S. Hernandez. Together, they form a team that fosters innovation and drives forward the understanding of complex pharmaceutical compounds. Their combined expertise nurtures a productive research environment that enhances the prospect of transformative therapies.

Conclusion

Peter L. Barker’s inventive contributions, exemplified by his recent patents, underscore a dedication to advancing pharmaceutical science. His work not only enhances drug formulations but also paves the way for improved therapeutic outcomes, solidifying his role as a pivotal innovator in the industry. Through his collaborations and continued research, Barker’s future endeavors promise to yield further advancements in pharmaceutical applications.